# FDA Inspection 1257940 - Baxalta US Inc. - January 30, 2025

Source: https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/b4a44b84-6f53-4177-98fd-8f8fa667b966
Source feed: FDA_Inspections

> FDA Inspection 1257940 for Baxalta US Inc. on January 30, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1257940
- Company Name: Baxalta US Inc.
- Inspection Date: 2025-01-30
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1257940 - 2025-01-30](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/eed36837-9867-48ff-b4ab-b05c8d41185e)
- [FDA Inspection 1146227 - 2021-07-01](https://www.keypedia.com/records/fda_inspections/baxalta-us-inc/a8280b3f-b05a-4cc7-8c41-50905361760f)

Company: https://www.keypedia.com/companies/baxalta-us-inc/dbfac016-3c29-44aa-845b-d79000c4abd2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d